This list is an analysis based on recent market events. It's not an investment recommendation.
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
FAQs
What is Acepodia stock price today?▼
The current price of 6976.TWO is TWD12.75 TWD — it has increased by +2.41% in the past 24 hours. Watch Acepodia stock price performance more closely on the chart.
What is Acepodia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Acepodia stocks are traded under the ticker 6976.TWO.
Is Acepodia stock price growing?▼
6976.TWO stock has fallen by -1.92% compared to the previous week, the month change is a -0.39% fall, over the last year Acepodia has showed a -18.53% decrease.
What is Acepodia market cap?▼
Today Acepodia has the market capitalization of 7.43B
What is Acepodia revenue for the last year?▼
Acepodia revenue for the last year amounts to 185,000 TWD.
What is Acepodia net income for the last year?▼
6976.TWO net income for the last year is -754.4M TWD.
How many employees does Acepodia have?▼
As of November 4, 2026, the company has 20 employees.
In which sector is Acepodia located?▼
Acepodia operates in the Health & Wellness sector.
When did Acepodia complete a stock split?▼
Acepodia has not had any recent stock splits.
Where is Acepodia headquartered?▼
Acepodia is headquartered in Grand Cayman, Cayman Islands.